doc. MUDr. Alexandr Poprach, Ph.D.
Associate professor, Comprehensive Cancer Care Department
Total number of publications: 137
2024
-
Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report
CASE REPORTS IN ONCOLOGY, year: 2024, volume: 17, edition: 1, DOI
-
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations
Cancer immunology, immunotherapy, year: 2024, volume: 73, edition: 8, DOI
2023
-
Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma
Targeted Oncology, year: 2023, volume: 18, edition: November 2023, DOI
-
Long non-coding RNAs enable precise diagnosis and prediction of early relapse after nephrectomy in patients with renal cell carcinoma
Journal of cancer research and clinical oncology, year: 2023, volume: 149, edition: 10, DOI
-
Next generation proteomics identifies a potential protein marker of poor response to tyrosine kinase inhibitors in metastatic renal cell carcinoma
Year: 2023, type: Conference abstract
-
Proteotype classification of localized and metastatic renal cell carcinoma for prognosis and therapy response
Year: 2023, type: Conference abstract
-
Proteotype classification of metastatic and localized renal cell carcinomas for prognosis and therapy response
Year: 2023, type: Conference abstract
-
Proteotypová klasifikace renálního karcinomu
Year: 2023, type:
-
Transmembrane glycoprotein GPNMB is a potential marker of poor response of metastatic renal cell carcinoma to tyrosine kinase receptor inhibitor treatment
Year: 2023, type: Conference abstract
2022
-
A large-scale assay library for targeted protein quantification in renal cell carcinoma tissues
Proteomics, year: 2022, volume: 22, edition: 7, DOI